I don't disagree with anything you have said. Getting data out of China could be an issue but if revenue resulted, it would help to move trials around the world along. I assume that the FDA would only accept data from their approved trials but it might get RVX doing some of these trials. Also, there are many Asians that are Caucasian even though we don't think of them as such because they aren't as white as us. They are still much closer racially related to us with is important for racial diversity. The sub-continent and up to the Middle East is populated with Caucasians.